Startseite>>Signaling Pathways>> MAPK Signaling>> cAMP>>Sp-8-bromo-Cyclic AMPS (sodium salt)

Sp-8-bromo-Cyclic AMPS (sodium salt) (Synonyms: 8Bromoadenosine 3',5'cyclic Monophosphothioate SPIsomer, Sp8bromocAMPS)

Katalog-Nr.GC44920

Sp-8-bromo-cyclic AMPS (Sp-8-bromo-cAMPS) is a cell-permeable, cAMP analog that combines an exocyclic sulfur substitution in the axial position of the cyclophosphate ring with a bromine substitution in the adenine base of cAMP.

Products are for research use only. Not for human use. We do not sell to patients.

Sp-8-bromo-Cyclic AMPS (sodium salt) Chemische Struktur

Cas No.: 1573115-90-8

Größe Preis Lagerbestand Menge
500μg
163,00 $
Auf Lager
1mg
310,00 $
Auf Lager
5mg
1.058,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Sp-8-bromo-cyclic AMPS (Sp-8-bromo-cAMPS) is a cell-permeable, cAMP analog that combines an exocyclic sulfur substitution in the axial position of the cyclophosphate ring with a bromine substitution in the adenine base of cAMP. This configuration pools the structural features of two established cyclic-AMP-dependent protein kinase (PKA) activators, 8-bromo-cAMP and Sp-cAMPS . Sp-8-bromo-cAMPS is a PKA agonist (EC50 = 1.5 µM) with improved lipophilicity and is not readily degraded by cyclic nucleotide phosphodiesterases.

Bewertungen

Review for Sp-8-bromo-Cyclic AMPS (sodium salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 38 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Sp-8-bromo-Cyclic AMPS (sodium salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.